Decision Making with Prostate Cancer: A Multiple-Objective Model with Uncertainty

A patient who has been diagnosed with prostate cancer must make a difficult treatment decision. The available alternatives have varying cure rates and probabilities of side effects over a period of many years. This paper describes a well-informed, objective, and personalized model for comparing treatments to help a patient make the best treatment decision.

[1]  Ralph L. Keeney,et al.  Multiplicative Utility Functions , 1974, Oper. Res..

[2]  A. Elstein.  Clinical judgment: psychological research and medical practice. , 1976, Science.

[3]  R. L. Keeney,et al.  Decisions with Multiple Objectives: Preferences and Value Trade-Offs , 1977, IEEE Transactions on Systems, Man, and Cybernetics.

[4]  Rakesh K. Sarin,et al.  Measurable Multiattribute Value Functions , 1979, Oper. Res..

[5]  Joseph S. Pliskin,et al.  Utility Functions for Life Years and Health Status , 1980, Oper. Res..

[6]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[7]  D. Feeny,et al.  Utilities and Quality-Adjusted Life Years , 1989, International Journal of Technology Assessment in Health Care.

[8]  Floyd J. Fowler,et al.  Watchful Waiting vs Immediate Transurethral Resection for Symptomatic Prostatism: The Importance of Patients’ Preferences , 1989 .

[9]  C J McDonald,et al.  Medical Heuristics: The Silent Adjudicators of Clinical Practice , 1996, Annals of Internal Medicine.

[10]  F. Marshall,et al.  Risk factors for urinary incontinence after radical prostatectomy. , 1996, The Journal of urology.

[11]  I. Milsom,et al.  Urinary incontinence and lower urinary tract symptoms: an epidemiological study of men aged 45 to 99 years. , 1997, The Journal of urology.

[12]  K. Wallner,et al.  Comparison of outcome and morbidity of 3-dimensional conformal radiotherapy versus transperineal permanent I-125 implantation for early stage prostatic cancer , 1998 .

[13]  F. Vicini,et al.  The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer. , 1999, International journal of radiation oncology, biology, physics.

[14]  B. Chauvet,et al.  [Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer]. , 1999, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[15]  J. Miyamoto,et al.  Quality-Adjusted Life Years (QALY) Utility Models under Expected Utility and Rank Dependent Utility Assumptions. , 1999, Journal of mathematical psychology.

[16]  W. Catalona,et al.  Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. , 1999, The Journal of urology.

[17]  W. Catalona,et al.  Contemporary results of anatomic radical prostatectomy , 1999, CA: a cancer journal for clinicians.

[18]  M. Zelefsky,et al.  Combined 3‐dimensional conformal radiotherapy and transperineal Pd‐103 permanent implantation for patients with intermediate and unfavorable risk prostate cancer , 2000, International journal of cancer.

[19]  A. Araujo,et al.  Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. , 2000, The Journal of urology.

[20]  L. Potters,et al.  Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. , 2000, International journal of radiation oncology, biology, physics.

[21]  K. Wallner,et al.  Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. , 2000, International journal of radiation oncology, biology, physics.

[22]  M. Kattan,et al.  Potency after permanent prostate brachytherapy for localized prostate cancer. , 2001, International journal of radiation oncology, biology, physics.

[23]  A. Partin,et al.  Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. , 2001, The Urologic clinics of North America.

[24]  C C Ling,et al.  High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. , 2001, The Journal of urology.

[25]  R. Stock,et al.  Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. , 2001, The Journal of urology.

[26]  Michael J. Zelefsky,et al.  High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. , 2002, International journal of radiation oncology, biology, physics.

[27]  E. Klein,et al.  Defining sexual outcomes after treatment for localized prostate carcinoma , 2002, Cancer.

[28]  D. Kuban,et al.  Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. , 2003, International journal of radiation oncology, biology, physics.

[29]  P. Walsh.  A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. , 2003, The Journal of urology.

[30]  A. Zietman,et al.  Influence of follow-up bias on PSA failure after external beam radiotherapy for localized prostate cancer: results from a 10-year cohort analysis. , 2003, International journal of radiation oncology, biology, physics.

[31]  Steven Piantadosi,et al.  Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. , 2003, The Journal of urology.

[32]  Gordon Hazen,et al.  Multiattribute Structure for QALYs , 2004, Decis. Anal..

[33]  William J Catalona,et al.  Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. , 2004, The Journal of urology.

[34]  Daniel Eayres,et al.  Life expectancy calculator: LA and ward level , 2004 .

[35]  L. Potters,et al.  Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. , 2002, International journal of radiation oncology, biology, physics.

[36]  Karen E Bremner,et al.  A Review and Meta-Analysis of Prostate Cancer Utilities , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.